Alberto F Sobrero (Alberto Sobrero)

Publication Activity (10 Years)

Years Active: 2021-2022
Publications (10 Years): 3

Top Topics

Metastatic Colorectal Cancer

Top Venues

Future oncology (London, England)

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

JNCI cancer spectrum

This page only lists publications with an associated author ORCID identifier.

Publications

Nadine Jackson McCleary, William S Harmsen, Ellana Haakenstad, James M Cleary, Jeffrey A Meyerhardt, Zalcberg John, Richard A Adams, Axel Grothey, Alberto F Sobrero, Eric Van Cutsem, Richard M Goldberg, Marc Peeters, Josep Tabernero, Matthew T Seymour, Leonard B Saltz, Bruce J Giantonio, Dirk Arnold, Mace L Rothenberg, Miriam Koopman, Hans-Joachim Schmoll, Henry C Pitot, Paulo M Hoff, Niall C Tebbutt, Gianluca Masi, John Souglakos, Carsten Bokemeyer, Volker Heinemann, Takayuki Yoshino, Benoist Chibaudel, Aimery deGramont, Qian Shi, Stuart M Lichtman
Metastatic Colorectal Cancer Outcomes by Age Among ARCAD First- and Second-Line Clinical Trials. JNCI cancer spectrum 6 (2) (2022)
Timothy J Iveson, Alberto F Sobrero, Takayuki Yoshino, Ioannis Souglakos, Fang-Shu Ou, Jeffrey P Meyers, Qian Shi, Axel Grothey, Mark P Saunders, Roberto Labianca, Takeharu Yamanaka, Ioannis Boukovinas, Niels Henrik Hollander, Fabio Galli, Kentaro Yamazaki, Vassilis Georgoulias, Rachel Kerr, Eiji Oki, Sara Lonardi, Andrea Harkin, Gerardo Rosati, James Paul
Duration of Adjuvant Doublet Chemotherapy (3 or 6 months) in Patients With High-Risk Stage II Colorectal Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (6) (2021)
Arvind Dasari, Alberto F Sobrero, James C Yao, Takayuki Yoshino, William Schelman, Zhao Yang, Caly Chien, Marek Kania, Josep Tabernero, Cathy Eng
FRESCO-2: a global Phase III study investigating the efficacy and safety of fruquintinib in metastatic colorectal cancer. Future oncology (London, England) 17 (24) (2021)